Last filing: May 15, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Xylem Inc. (XYL) | Director | Dec 13, 2012 | May 15, 2026 |
| West Pharmaceutical Services (WST) | Director | Feb 20, 2020 | May 6, 2026 |
| Revvity (RVTY) | Former Chairman and CEO, Director | Oct 24, 2003 | Feb 14, 2019 |
Also a director at
West Pharmaceutical Services (WST), Revvity (RVTY) (no filing in the last 18 months)
Recent filings
The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.